EV325/#391 Disitamab Vedotin Combined Therapy for HER2 Positive Platinum-Sensitive Ovarian Cancer (diversity Study): a Study Protocol of Prospective Multicenter Phase II Trial
International Journal of Gynecological Cancer（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined